You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Drug misuse

Drug use disorders in adults

  • Quality standard
  • Reference number: QS23
  • Published:  19 November 2012
  • Quality standard
  • Tools and resources
  • History
Download (PDF)
  • Overview
  • Quality statements
  • Quality statement 1: Needle and syringe programmes
  • Quality statement 2: Assessment
  • Quality statement 3: Families and carers
  • Quality statement 4: Blood-borne viruses
  • Quality statement 5: Information and advice
  • Quality statement 6: Keyworking – psychosocial interventions
  • Quality statement 7: Recovery and reintegration
  • Quality statement 8: Formal psychosocial interventions and psychological treatments
  • Quality statement 9: Continued treatment and support when abstinent
  • Quality statement 10: Residential rehabilitative treatment
  • Update information
  • About this quality standard

Update information

Minor changes since publication

September 2024: References, data sources and links have been updated throughout. Structure measures were also removed where they replicated process measures.

June 2022: The definition of psychological treatments in statement 8 has been updated to link to the updated NICE guideline on depression in adults. Links and references have been updated throughout.

April 2014: NICE's guideline on needle and syringe programmes has been updated. References and links to this guideline have been updated throughout.


Next page About this quality standard Previous page Quality statement 10: Residential rehabilitative treatment
Back to top